Cancer stem cells: advances in knowledge and implications for cancer therapy

X Chu, W Tian, J Ning, G Xiao, Y Zhou… - … and Targeted Therapy, 2024 - nature.com
Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …

Cancer stem cell (CSC) resistance drivers

M Najafi, K Mortezaee, J Majidpoor - Life sciences, 2019 - Elsevier
Cancer stem cells (CSCs) are a population of self-renewal cells with high tumorigenic
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …

ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis

R Karki, B Sundaram, BR Sharma, SJ Lee… - Cell reports, 2021 - cell.com
Cell death provides host defense and maintains homeostasis. Zα-containing molecules are
essential for these processes. Z-DNA binding protein 1 (ZBP1) activates inflammatory cell …

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma

W Wang, Z Lu, M Wang, Z Liu, B Wu, C Yang… - Frontiers in …, 2022 - frontiersin.org
Background Copper ions are essential for cellular physiology. Cuproptosis is a novel
method of copper-dependent cell death, and the cuproptosis-based signature for glioma …

FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling

H Huang, Y Wang, M Kandpal, G Zhao, H Cardenas… - Cancer research, 2020 - AACR
Abstract N 6-Methyladenosine (m6A) is the most abundant modification of mammalian
mRNAs. RNA methylation fine tunes RNA stability and translation, altering cell fate. The fat …

Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling

J Qian, BL LeSavage, KM Hubka, C Ma… - The Journal of …, 2021 - Am Soc Clin Investig
Ovarian cancer is the leading cause of gynecological malignancy–related deaths, due to its
widespread intraperitoneal metastases and acquired chemoresistance. Mesothelial cells are …

[HTML][HTML] Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth

RK Malireddi, R Karki, B Sundaram… - …, 2021 - journals.aai.org
Resistance to cell death is a hallmark of cancer. Immunotherapy, particularly immune
checkpoint blockade therapy, drives immune-mediated cell death and has greatly improved …

Cancer stem cells—key players in tumor relapse

M Marzagalli, F Fontana, M Raimondi, P Limonta - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the hardest pathologies to fight, being one of the main
causes of death worldwide despite the constant development of novel therapeutic strategies …

Drug-tolerant persister cells in cancer therapy resistance

PK Dhanyamraju, TD Schell, S Amin, GP Robertson - Cancer research, 2022 - AACR
One of the current stumbling blocks in our fight against cancer is the development of
acquired resistance to therapy, which is attributable to approximately 90% of cancer-related …

A decade of cell death studies: Breathing new life into necroptosis

I Khan, A Yousif, M Chesnokov, L Hong… - Pharmacology & …, 2021 - Elsevier
Programmed cell death (PCD) has been a major area of constantly growing interest over the
last three decades. Originally, apoptosis was considered the only mechanistic pathway for …